The laboratory of Mark Rubinstein investigates how the immune system is impaired by cancer cells and develops strategies to overcome immune suppression. The lab focuses on therapeutic approaches including immune checkpoint therapy, adoptive cell therapy, and vaccines. This research aims to deepen understanding of tumor biology, identify novel therapies, and uncover biomarkers.

The laboratory of Mark Rubinstein investigates how the immune system is impaired by cancer cells and develops strategies to overcome immune suppression. The lab focuses on therapeutic approaches including immune checkpoint therapy, adoptive cell therapy, and vaccines. This research aims to deepen understanding of tumor biology, identify novel therapies, and uncover biomarkers.